Novartis Pharmaceuticals is currently recruiting patients into the APPEAR C3G study. This is a 6 month randomised controlled trial comparing iptacopan with placebo, and in the UK is taking place at the Hammersmith Hospital in London and the Royal Victoria Infirmary in Newcastle. In the UK they are keen to identify further patients who wish to participate, particularly those within relatively easy striking distance of either London or Newcastle.
Further details, including other countries/sites that are recruiting, and eligibility criteria, can be found on the ClinicalTrials.gov website under the trial number NCT04817618.
You should talk to your doctor before participating in any trial.
Get the latest
For up-to-date news and information visit our news or join our mailing list below:
View upcoming events and dates in our MPGN/DDD Support Group calendar.
Find out what we’re doing right now and how you can help: